Eric Venker
CIK: 0001801917
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (124 total)
- Oct 28, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct200K shares at avg. $36.59$7.3M - Oct 20, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct185.9K shares at avg. $35.09$6.5M - Oct 20, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct14.1K shares at avg. $35.42$501K - Oct 2, 2026IMVT
Immunovant, Inc.
Sale(S)Direct3.5K shares at avg. $34.11$120K - Oct 1, 2026IMVT
Immunovant, Inc.
Disposition(D)Direct85.9K shares at avg. $33.65$2.9M - Oct 1, 2026IMVT
Immunovant, Inc.
Exercise(M)Direct92.2K shares at avg. $14.46$1.3M - Sep 30, 2026ROIV
Roivant Sciences Ltd.
Exercise(M)Direct200K shares at avg. $3.85$770K - Sep 30, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct200K shares at avg. $36.62$7.3M - Aug 28, 2026ROIV
Roivant Sciences Ltd.
Exercise(M)Direct200K shares at avg. $3.85$770K - Aug 28, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct33.8K shares at avg. $36.44$1.2M - Aug 28, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct166.2K shares at avg. $35.63$5.9M - Aug 20, 2026ROIV
Roivant Sciences Ltd.
Tax Payment(F)Direct13.9K shares at avg. $36.84$512K - Jul 27, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct200K shares at avg. $34.95$7.0M - Jul 27, 2026ROIV
Roivant Sciences Ltd.
Exercise(M)Direct200K shares at avg. $3.85$770K - Jul 2, 2026IMVT
Immunovant, Inc.
Sale(S)Direct3.1K shares at avg. $38.48$119K - Jul 1, 2026IMVT
Immunovant, Inc.
Disposition(D)Direct86.6K shares at avg. $38.14$3.3M - Jul 1, 2026IMVT
Immunovant, Inc.
Exercise(M)Direct92.2K shares at avg. $14.46$1.3M - Jun 24, 2026ROIV
Roivant Sciences Ltd.
Exercise(M)Direct200K shares at avg. $3.85$770K - Jun 24, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct46.2K shares at avg. $33.51$1.5M - Jun 24, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct153.8K shares at avg. $33.05$5.1M - May 22, 2026ROIV
Roivant Sciences Ltd.
Exercise(M)Direct200K shares at avg. $3.85$770K - May 22, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct200K shares at avg. $30.27$6.1M - May 20, 2026ROIV
Roivant Sciences Ltd.
Tax Payment(F)Direct34.5K shares at avg. $32.41$1.1M - Apr 20, 2026ROIV
Roivant Sciences Ltd.
Sale(S)Direct200K shares at avg. $29.59$5.9M - Apr 20, 2026ROIV
Roivant Sciences Ltd.
Exercise(M)Direct200K shares at avg. $3.85$770K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 28, 2026 |  ROIV Roivant Sciences Ltd. | Sale(S) | 200,000 | $36.59 | $7,318,000 | Direct |
| Oct 20, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 185,856 | $35.09 | $6,521,687 | Direct |
| Oct 20, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 14,144 | $35.42 | $500,980 | Direct |
| Oct 2, 2026 |  IMVT Immunovant, Inc. | Sale(S) | 3,506 | $34.11 | $119,590 | Direct |
| Oct 1, 2026 | IMVT Immunovant, Inc. | Disposition(D) | 85,886 | $33.65 | $2,890,064 | Direct |
| Oct 1, 2026 | IMVT Immunovant, Inc. | Exercise(M) | 92,187 | $14.46 | $1,333,024 | Direct |
| Sep 30, 2026 | ROIV Roivant Sciences Ltd. | Exercise(M) | 200,000 | $3.85 | $770,000 | Direct |
| Sep 30, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 200,000 | $36.62 | $7,324,000 | Direct |
| Aug 28, 2026 | ROIV Roivant Sciences Ltd. | Exercise(M) | 200,000 | $3.85 | $770,000 | Direct |
| Aug 28, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 33,818 | $36.44 | $1,232,328 | Direct |
| Aug 28, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 166,182 | $35.63 | $5,921,065 | Direct |
| Aug 20, 2026 | ROIV Roivant Sciences Ltd. | Tax Payment(F) | 13,909 | $36.84 | $512,408 | Direct |
| Jul 27, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 200,000 | $34.95 | $6,990,000 | Direct |
| Jul 27, 2026 | ROIV Roivant Sciences Ltd. | Exercise(M) | 200,000 | $3.85 | $770,000 | Direct |
| Jul 2, 2026 | IMVT Immunovant, Inc. | Sale(S) | 3,092 | $38.48 | $118,980 | Direct |
| Jul 1, 2026 | IMVT Immunovant, Inc. | Disposition(D) | 86,629 | $38.14 | $3,304,030 | Direct |
| Jul 1, 2026 | IMVT Immunovant, Inc. | Exercise(M) | 92,188 | $14.46 | $1,333,038 | Direct |
| Jun 24, 2026 | ROIV Roivant Sciences Ltd. | Exercise(M) | 200,000 | $3.85 | $770,000 | Direct |
| Jun 24, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 46,234 | $33.51 | $1,549,301 | Direct |
| Jun 24, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 153,766 | $33.05 | $5,081,966 | Direct |
| May 22, 2026 | ROIV Roivant Sciences Ltd. | Exercise(M) | 200,000 | $3.85 | $770,000 | Direct |
| May 22, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 200,000 | $30.27 | $6,054,000 | Direct |
| May 20, 2026 | ROIV Roivant Sciences Ltd. | Tax Payment(F) | 34,483 | $32.41 | $1,117,594 | Direct |
| Apr 20, 2026 | ROIV Roivant Sciences Ltd. | Sale(S) | 200,000 | $29.59 | $5,918,000 | Direct |
| Apr 20, 2026 | ROIV Roivant Sciences Ltd. | Exercise(M) | 200,000 | $3.85 | $770,000 | Direct |
1-25 of 124 transactions
About Venker Eric
Venker Eric (SEC CIK 0001801917) files insider reports with the SEC as Chief Executive Officer of Immunovant, Inc. (IMVT) and President & Immunovant CEO of Roivant Sciences Ltd. (ROIV).
Signal8 holds 42 ownership filings by Venker Eric, all Form 4s, filed between Sep 24, 2024 and Oct 30, 2026. Those filings report 124 transactions, from Sep 20, 2024 to Oct 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Venker Eric's filings is in LONDON.
Recent filings by Venker Eric
- Oct 28, 2026: Open-market sale of ROIV shares (Form 4, code S).
- Oct 20, 2026: Open-market sales of ROIV shares (2 lines, Form 4, code S).
- Oct 2, 2026: Open-market sale of IMVT shares (Form 4, code S).
- Oct 1, 2026: Disposition to issuer transaction of IMVT shares (Form 4, code D).
- Oct 1, 2026: Option exercise of IMVT shares (Form 4, code M).
Other insiders filing for Immunovant, Inc. (IMVT)
- Girao Tiago, Chief Financial Officer
- Stout Jay S, Chief Technology Officer
- Van Tuyl Christopher, Chief Legal Officer
- Gloria Melanie, Chief Operating Officer
- Pande Atul, Director
- Fromkin Andrew J., Director